If you are taking a biologic therapy, such as infliximab (Remicade®), adalimumab (Humira®), vedolizumab (Entyvio®), or ustekinumab (Stelara®), to treat inflammatory bowel disease …

Nov 28, 2025 · Entyvio is used to treat moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) in adults. Entyvio infusion is administered intravenously for the first two …

Nov 25, 2025 · Entyvio (vedolizumab) is a crucial biologic therapy for inflammatory bowel diseases, but unlike many medications, it does not have a generic version. Because it is a …

Nov 28, 2025 · Quick Summary Entyvio is a brand-name biologic drug used for inflammatory bowel diseases, and no generic version exists. Alternative treatments called biosimilars are …

Apr 16, 2025 · Vedolizumab is the generic name for Entyvio, a biologic therapy used to treat moderate to severe Crohn’s disease and ulcerative colitis.

Oct 16, 2024 · Entyvio (Vedolizumab for Injection, for Intravenous Use ) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications …

Jul 31, 2024 · Find patient medical information for Entyvio (vedolizumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Jun 3, 2025 · Learn about Entyvio (vedolizumab) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

Medscape - Crohn disease and ulcerative colitis dosing for Entyvio, Entyvio Pen (vedolizumab), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & …

Feb 23, 2024 · Generic name: vedolizumab Brand name: Entyvio Dosage form: intravenous infusion (300 mg single-dose vial), subcutaneous injection (108 mg/0.68 mL prefilled syringe), …